Cluster 2 prevention of cardiovascular diseases
Cluster 2 prevention of cardiovascular diseases
I have two stents inserted in my heart and have been dealing with nerve-wracking irregular heartbeat my whole life. I decided to give Cardio Balance a try, and I thank God for it! Just after using it for a couple of weeks, my irregular heart beating became normal. I feel more ALIVE, young, and energetic.
ЧИТАТЬ ДАЛЕЕ ...
Cluster 2: prevention of cardiovascular form disease — A common way to better health Cardiovascular diseases are the leading causes of death. According to the world health organization (WHO), cases every year, millions of death and many of these cases are preventable. The good news is that Through targeted prevention measures, the risk can be significantly reduced. It is precisely here that the Cluster 2 sets for the prevention of cardiovascular diseases: It brings together researchers, Doctors, health authorities and civil society organisations to develop strategies for the prevention and implement. Why a Cluster? The challenge of prevention is multifaceted and requires an interdisciplinary approach. Risk factors such as hypertension, Diabetes, Obesity, lack of exercise, Smoking, and unhealthy diet are closely linked to each other. Individual measures are often not sufficient — it is a coherent set of needs, a multi-dimensional concept. The Cluster 2 creates the necessary framework in order to pool Knowledge and resources to take advantage of synergies and to increase the effectiveness of prevention programs. Objectives and priorities The Cluster has several key objectives: Early detection: the improvement of Screening programs for the early identification of risk factors. Education: informing the population about healthy way of life, risks, and individual possibilities for Prevention. Interventions: development and implementation of evidence-based prevention strategies, both at the individual and at the societal level. Data exchange: the creation of a common data platform for the analysis of Trends and evaluation of the measures. Network building: strengthening of the cooperation between clinics, medical practices, schools, companies and sports clubs. Practical Approaches Concrete measures of the cluster include: Regular health checks in workplaces and communities. Education programs in schools on the topic of heart health and healthy eating. Campaigns to reduce the consumption of tobacco and salt consumption. Promotion of physical activities, for example through free sports courses, or cycle networks. Digital Tools for self-monitoring of blood pressure and cholesterol. He Example: Community-Based Prevention In a number of model regions of the municipality were started based programs: house doctors, nutritionists, and athletic trainers work closely together. Citizens receive individual counseling, opportunities for participation in exercise programs, and access to cost-effective health services. First results show that Such local approaches to reduce the risk of heart attacks and stroke significantly. Conclusion The Cluster 2 for the prevention of cardiovascular disease is more than just a project — it is an Alliance for health. By linking science, practice, and society, he creates the conditions to cardiovascular reduce diseases in the long term. The investment in prevention pays off: it saves lives, reduces cost-of-illness and strengthens the quality of life of the population. The way forward is clear — now is the time to go to see him together.
Cardio Balance treats digestive issues by promoting the absorption of nutrients, and it helps in the elimination of toxic wastes. So, you’re unlikely to experience stomach ache as a side effect. Cluster 2 prevention of cardiovascular diseases. Ginagamit ito bilang biologically active na pampadagdag sa pagkain — dagdag na pinagmumulan ng mga bitamina — B2, B6, C, mga organikong asido — mansanas, succinic, glutamine. Mga sangkap: malic acid, succinic acid, glutamic acid, badan extract, ascorbic acid, bitamina B2, B6.
Blueberry from the pressure in hypertension
Diet 10 in cardiovascular diseases restrictions
http://russiafoto.ru/posts/60986-covid-cardiovascular-disease.html
https://mytube.by/articles/2914-prevention-of-cardiovascular-diseases-memo.html
Isang malawak na pagpipilian ng mga gamot mismo pati na rin ng mga pamamaraan para sa pagbawas ng gamot mula sa mataas na presyon ang nagbibigay-daan sa iyo na pumili ng pinaka-komportableng programa ng paggamot – ang abot-kaya sa gastos, na may minimal na pagpapakita ng mga side effect, at isinasaalang-alang ang ibang kasamang sakit. Kapag matagal ang pag-inom ng tabletas at binabago ng doktor ang gamot, ito ay dahil ang ilang gamot ay may katangian na magdulot ng pagkagumon, na nagreresulta sa kaunting pagbaba ng bisa nito. Bukod dito, hindi lahat ng grupo ng gamot ay angkop para sa mga pasyente sa iba't ibang edad, at may mga limitasyon din sa pagiging compatible nito sa ibang uri ng gamot. Not all cases of high Blood pressure present symptoms of headaches. However, when there is a sudden surge in blood pressure, it can cause a headache. The headache feels like throbbing pain and occurs on both sides of the head. It gets worse with physical activity. (It’s also a sign of a medical emergency).
Of course! Here is a scientific Text is in German on the subject of Edarbi as an effective drug against high blood pressure: Edarbi: A modern approach to the therapy of arterial hypertension The arterial hypertension (high blood pressure) is a global health problem and is considered to be one of the main risk factors for cardiovascular disease, including heart attack, stroke, and congestive heart failure. The effective reduction in blood pressure is, therefore, of crucial importance for the prevention of these life-threatening complications. In this context, Edarbi (active ingredient: Azilsartan medoxomil) has established itself as a highly effective and safe drug for the long-term treatment of hypertension. Pharmacological Mechanism Of Action Edarbi belongs to the class of Angiotensin II receptor antagonists (AT1‑receptor blocker). The active ingredient Azilsartan medoxomil selectively inhibits the binding of Angiotensin II to its AT1 receptors, the vessels mainly in the blood, heart, and kidneys are located. Through this inhibition, the following effects can be achieved: Vasodilation (Vascular Dilation), Reduction in Aldosterone secretion, Decrease of peripheral vascular resistance, Lowering of blood pressure. In comparison to other AT1 receptor blocker Azilsartan shows a particularly strong and long-lasting binding to the receptors, which leads to a stable blood pressure control over 24 hours. Clinical Efficacy Several randomized controlled trials (RCTs) have demonstrated the efficacy of Edarbi in patients with mild-to-moderate hypertension. In a pivotal study, it was shown that a daily dose of 40 mg or 80 mg Azilsartan medoxomil leads to a significant reduction in both systolic and diastolic blood pressure, compared to Placebo and other antihypertensive drugs such as Valsartan or Olmesartan. Particularly, the effectiveness is emphasized in patients who do not respond to other AT1‑Blocker inadequate. Edarbi also shows in elderly patients and in patients with metabolic syndrome have a good efficacy and tolerability. Safety and tolerability In clinical studies, Edarbi showed a favorable safety profile. The most common side effects were: Headache, Dizziness, Fatigue, slight hypotension. However, these effects occur are usually mild and rarely lead to discontinuation of therapy. Compared to ACE inhibitors (e.g. Ramipril) gives Edarbi no irritating cough, which improves the long-term patient compliance significantly. Dosage and administration Diefangsdosis is 40 mg once a day. In case of insufficient reduction in blood pressure, the dose can be increased to 80 mg/day. Edarbi, regardless of the meals. In patients with moderate renal impairment no dose adjustment is required; in the case of severe kidney or liver disease, the therapy should be carried out with particular caution. Conclusion Edarbi (Azilsartan medoxomil), due to its high effectiveness, long-lasting effect and good tolerability is a valuable adjunct in the therapy of arterial hypertension. It is, in particular, patients who do not respond to other antihypertensives inadequate or side effects, offers an effective Alternative. An individual Benefit-risk assessment by the attending physician, however, is always required. If you want, I can customize the Text, cut or other aspects (e.g., direct comparisons with other drugs, long-term data, cost‑Benefit considerations), complement!